Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy

Langenbeck's Archives of Surgery

Volumn 397, Issue 3, 2012, Pages 397-405

  Cucchetti, Alessandro ^a   Ercolani, Giorgio ^a   Cescon, Matteo ^a   Di Gioia, Paolo ^a   Peri, Eugenia ^a   Brandi, Giovanni ^b   Pellegrini, Sara ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chemotherapy; Colorectal neoplasm; Hepatic resection; Liver metastases; Morbidity

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB; RALTITREXED;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CAUSE OF DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEVER; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURGICAL INFECTION; SURGICAL MORTALITY; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PROPENSITY SCORE;

EID: 84859870637     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0894-4     Document Type: Article

References (33)

1. Ries LAG, Melbert D, Krapcho M, SEER Cancer Statistics Review, 1975-2005, National Cancer Institute (2008) Bethesda, MD, based on November 2007 SEER data submission. [updated 2008; cited]. http://seer.cancer.gov/csr/1975-2005/
2. Cancer trends in the UK (2006) Available at http://www.cancerresearchuk. org/. Last accessed 01/02/2011
3. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241-1246
4. Sugarbaker PH (1990) Surgical decision making for large bowel cancer metastatic to the liver. Radiology 174:621-626
5. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410 (Pubitemid 24167517)
6. Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-520
7. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8:347-353 (Pubitemid 32422861)
8. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL (2010) Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 17:492-501
9. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P et al (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118-124
10. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072 (Pubitemid 46622116)
11. Welsh FK, Tilney HS, Tekkis PP, John TG, Rees M (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96:1037-1042 (Pubitemid 46608314)
12. Fong Y, Bentrem DJ (2006) CASH (chemotherapy-associated steatohepatitis) costs. Ann Surg 243:8-9 (Pubitemid 43054047)
13. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, EORTC Gastro-Intestinal Tract Cancer Group et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-1016 (Pubitemid 351392040)
14. Hewes JC, Dighe S, Morris RW, Hutchins RR, Bhattacharya S, Davidson BR (2007) Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg 31:353-364 (Pubitemid 46183523)
15. Sahajpal A, Vollmer CM Jr, Dixon E, Chan EK, Wei A, Cattral MS et al (2007) Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol 95:22-27 (Pubitemid 46122713)
16. Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16:35-41
17. Wicherts DA, de Haas RJ, Sebagh M, Saenz Corrales E, Gorden DL, Lévi F et al (2011) Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases. Br J Surg 98:399-407
18. Tamandl D, Gruenberger B, Klinger M, Herberger B, Kaczirek K, Fleischmann E et al (2010) Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study. Ann Surg 252:124-130
19. Zinsmeister AR, Connor JT (2008) Ten common statistical errors and how to avoid them. Am J Gastroenterol 103:262-266 (Pubitemid 351248714)
20. Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55
21. Blackstone EH (2002) Comparing apples and oranges. J Thorac Cardiovas Surg 123:8-15
22. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922-928
23. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications - a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213 (Pubitemid 38963009)
24. Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150-161
25. Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B et al (2011) Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 18:421-430
26. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460-466 (Pubitemid 38444550)
27. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853 (Pubitemid 40744790)
28. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860-868
29. Tanaka K, Adam R, Shimada H, Azoulay D, Lévi F, Bismuth H (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90:963-969 (Pubitemid 37026325)
30. Gruttadauria S, Saint Georges Chaumet M, Pagano D, Marsh JW, Bartoccelli C, Cintorino D et al (2011) Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. Surg Oncol 103:140-147
31. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860-869
32. Morris-Stiff G, Tan YM, Vauthey JN (2008) Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 34:609-614 (Pubitemid 351671976)
33. Nordlinger B, Vauthey JN, Poston G, Benoist S, Rougier P, Van Cutsem E (2010) The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. Clin Colorectal Cancer 9:212-218